Holen Sie sich die Stockscreener-App
15.32
4.31%
-0.69
Handel nachbörslich:
14.87
-0.45
-2.94%
Finanzdaten der Corvus Pharmaceuticals Inc-Aktie (CRVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.04%
10.57
|
10.26 | 9.922 | 8.105 | 7.255 |
| Depreciation and Amortization |
3.45%
0.028
|
0.029 | 0.022 | 0.035 | 0.02 |
| Operating Income/Loss |
3.04%
-10.57
|
-10.26 | -9.922 | -8.105 | -7.255 |
| Nonoperating Income/Loss |
81.65%
0.415
|
2.262 | -25.11 | - | - |
| Income/Loss Before Equity Method Investments |
29.24%
-9.834
|
-7.609 | 15.73 | -9.939 | -39.53 |
| Income/Loss From Equity Method Investments |
16.97%
-0.323
|
-0.389 | -0.539 | -2.174 | -0.682 |
| Income/Loss From Continuing Operations Before Tax |
29.24%
-9.834
|
-7.609 | 15.73 | -9.939 | -39.53 |
| Income/Loss From Continuing Operations After Tax |
22.96%
-9.834
|
-7.998 | 15.19 | -9.939 | -39.53 |
|
Net Income/Loss
|
26.99%
-10.16
|
-7.998 | 15.19 | -12.11 | -40.22 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6.51%
82.84
|
77.77 | 72.13 | 2.4719 | 66.70 |
| Diluted Average Shares |
6.51%
82.84
|
77.77 | 75.15 | 2.4719 | 66.70 |
| Basic Earnings Per Share |
20.00%
-0.12
|
-0.10 | 0.21 | -0.16 | -0.60 |
| Diluted Earnings Per Share |
20.00%
-0.12
|
-0.10 | -0.13 | -0.16 | -0.60 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):